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Monozygotic (MZ) and dizygotic (DZ) twins participate in research that partitions variance in health, disease,
and behavior into genetic and environmental components. However, there are other innovative roles for
twins in medical research. One such way is involving MZ and/or DZ twins in co-twin control-designed ran-
domized controlled trials (RCTs). To our knowledge, no reviews have been conducted that summarizes the
involvement of twins in RCTs. Therefore, we conducted a systematic literature search using the U.S. Clinical
Trials Database, NHS electronic databases, MEDLINE, EMBASE, and PsychINFO for RCTs on publications
involving MZ and/or DZ twins as RCT participants. Out of the 186,027 clinical trials registered in the U.S.
clinical trial register ClinicaTrails.gov, only six RCTs used twins as participants. From 1,598 articles identi-
fied in our search, 50 peer-reviewed English language publications met our pre-defined inclusion criteria.
Sample sizes for RCTs have ranged from a total number of participants from 2 to 1,162; however, 32 (64%)
studies had a sample size of 100 or less, and of those, 12 (24%) had fewer than 10. Both MZ and DZ twins
have been recruited to the RCTs. In most instances (33/50) each twin from a pair were assigned to different
study arms. Most of those studies included MZ twins only. Despite the methodological advantages, the use
of MZ and DZ twins as participants in interventional RCTs appeared limited. The continuous development
of innovative twin designs, especially RCTs, indicates that twin research can extend beyond the more widely
recognized heritability estimates.
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Twins studies are best known for using the classical twin
design, based on comparisons between the similarity of
monozygotic (MZ) and dizygotic (DZ) twins to parti-
tion the variance in health, disease, and behavior into ge-
netic and environmental components, predominantly us-
ing observational study designs (Boomsma et al., 2002; van
Dongen et al., 2012)
Studies involving twins have become increasingly rele-
vant due to the continuous work of twin registries and stud-
ies that have, collectively, amassed data and biologicalmate-
rial on hundreds of thousands of twins, and have provided
a valuable resource for studying complex genetic pheno-
types and their underlying biology (Hur & Craig, 2013).
The availability of longitudinal data through the Interna-
tional Society of Twin Studies and International Network
of Twin Registries (INTR) is also proving to be a valuable
resource, not only for new studies but also for global collab-
orations (Buchwald et al., 2014). Data derived from a col-
laboration of 54 international twin cohort databases par-
ticipating in the CODATwins Project is a prime example
(Jelenkovic et al., 2015, 2016; Silventoinen et al., 2015, 2016;
Yokoyama et al., 2016).
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Within-pair comparisons of phenotypically discordant
MZ and DZ twin pairs through an observational co-twin
controlled design can illuminate the non-shared environ-
mental differences influencing human traits. However, such
comparisons are arguably more efficient in intervention co-
twin control studies using phenotypically concordant pairs,
where one twin is randomly assigned to receive the inter-
vention and the other twin acts as their control. A com-
parison between the co-twin control design in intervention
and non-intervention studies, along with other novel utili-
ties of this design, have been discussed in detail previously
(Plomin & Haworth, 2010).
The term ‘intervention’ refers broadly to any clinical ma-
neuver offered to study participants that may have an effect
on their health status (Jadad, 1998). Randomized controlled
trials (RCTs) are considered the gold standard for testing
interventions and ‘the most rigorous way of determining
whether a cause–effect relationship exists between treat-
ment and outcome and for assessing the cost effectiveness
of a treatment’ (Sibbald & Roland, 1998, p. 201). Random
allocation provides participants the same chance of being
assigned to each of the treatment groups (Altman, 1991).
The purpose of randomallocation is to ensure that the char-
acteristics of participants are as similar as possible across
treatment groups prior to the initiation of an intervention
(baseline). If randomization is done properly, it reduces the
risk of a serious imbalance in known and unknown fac-
tors that could influence the clinical course of the partici-
pants. Therefore, any significant differences between treat-
ment groups in the outcome of interest can be attributed to
the intervention and not to any unidentified factor(s).
However, involving MZ twins in a co-twin control-
designed RCT has advantages over the traditional RCT
involving unrelated individuals. The co-twin control de-
sign can increase statistical power and provide perfect
control for many of the potential confounding factors that
could be imbalanced between treatment groups by chance,
especially genetic makeup and age. The latter is particularly
relevant to RCTs in children, where age matching is often a
challenge. However, recruiting children in RCTs has ethical
implications and needs especially strict ethical oversight.
DZ twins may also allow for matching due to shared
environment as well as some genetic component and age,
which can potentially justify the choice for recruiting DZ
twins rather than siblings for a study. However, challenges
such as teasing out individual factors in the context of
complex interacting contributors may arise when using DZ
twins in RCTs. It is also believed that the co-twin control
RCT approach will have the additional advantage of re-
quiring a relatively smaller sample size without reducing
the statistical power (Plomin & Haworth, 2010). However,
if twins from the same pair are randomly assigned to the
same treatment group or independently of each other,
rather than to different treatment groups as in the co-twin
control design, the benefits in sample size for an RCT
involving twins may be lost (Yelland et al., 2017). Inter-
vention studies involving twins do exist in the literature.
One such trial testing the effect of Vitamin C intake on
common cold symptoms found that the relative power of
this design compared to an unpaired design could be 2–14
times stronger, which means an unpaired study design
would require much larger sample sizes to detect the same
effect (Carr et al., 1981; Martin et al., 1982).
However, in our opinion the full advantages and the ra-
tionale for involving twins in RCTs have not been ade-
quately discussed or explored. Therefore, we carried out
this review as the first step to identify studies using twins
as participants for RCTs. In-depth analyses of the quality
of individual studies and methodological issues of these
studies or meta-analysis was not an aim of this review. In
addition, a meta-analysis is not possible due to the hetero-
geneity of such studies and the varying interventions tested,
resulting in no single treatment effect to be estimated. In-
stead, we aimed to identify all published material including
RCTs involving only twins as participants up until 2015, us-
ing the selection criteria described below, and to summa-
rize basic trial characteristics including sample size, inclu-
sion criteria, whether trials include only MZ, DZ or both,
and randomization method (i.e., whether same-pair twins
were randomly assigned to the same treatment group inde-
pendent of each other, or to different treatment groups in a
co-twin control design).
Materials and Methods
A comprehensive search was carried out using the fol-
lowing databases: USA clinical trial (https://clinicaltrials.
gov/),MEDLINE (1946–2015), EMBASE (1974–2015), and
PsychINFO (1806–2015). We also performed an extensive
search using PubMed (all publications until March 2015).
Searches were confined to articles in English.
In the NHS library electronic database searches (MED-
LINE, EMBASE, and PsychINFO), the search terms ‘twins’,
‘randomi*’, ‘control*’, and ‘trial*’ with Boolean operator
AND was used in ‘title and abstract’. Each database was
searched individually using the search terms. This allowed
for all alternative spelling (randomised and randomized),
variations of control (control, controls, and controlled) and
singular or plural trial (trial and trials) to be searched simul-
taneously. The search terms used for the PubMed search
also took all of these variations into account (as per theNHS
library search).
Data Extraction
Data were extracted by one reviewer (DG), and then
checked independently by a second reviewer (AS). All pub-
lications identified in the searches were searched for dupli-
cates. Eligibility for inclusion in the review was decided by
DG and AS. Full versions of publications selected were ob-
tained and reviewed independently by three authors (AS,
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FIGURE 1
PRISMA diagram to illustrate the literature search process and the resulting number of reviewed articles from USA Clinical Trial database.
DG, and TS). Any discrepancy in judgments was resolved
through consensus. Abstracts eligible for inclusion were
confined to those reporting on a RCT that had used only
twins as study participants but not mothers pregnant with
twins. Information was extracted from each of the studies
relating to authors, study location, database, twin registry
(if any), condition, primary outcome, sample size, eligible
age, eligible sex, zygosity, twin assignment (same treatment
groups, different treatment groups, or independent alloca-
tion), masking, and control arm.
Results
U.S. Clinical Trial Database
The initial search using the U.S. clinical trial database
(186,027 clinical trials registered) resulted in a total of 90
clinical trials. Of these, 50 studieswere registeredwith twins
as study participants, and 40 studies were registered with
mothers who were pregnant with twins as study partici-
pants. Of the 90 twin studies, there were 29 RCTs. Of these,
23 had used mothers pregnant with twins as the study par-
ticipants and only six studies had recruited twins as the
study participants (Figure 1).
Extended Search Using Other Databases
After taking into account all duplicates and discounting pa-
pers including mothers pregnant with twins, the NHS li-
brary searches gave a total of 51 papers on RCTs using twins
as study participants; 47 from MEDLINE, and a further 4
papers not found inMEDLINEwere found in EMBASE.No
additional papers were found in PsychINFO.
PubMed searches gave an additional eight papers us-
ing twins as study participants that were not found in ei-
ther the MEDLINE or EMBASE search. The search term
‘Twins and Randomized Control Trial’ found two papers;
the term ‘Twins and Randomised Controlled Trial’ found
five; and the term ‘Twins and Randomised Control Trials’
found one. The search terms ‘Twins and Randomised Con-
trolled Trial’ and ‘Twins and Randomised controlled trials’
gave the exact same result when substituting the ‘s’ for a
‘z’ in the word ‘randomised’. The full text of all 59 poten-
tially relevant papers was examined in more detail, and 50
were consistent with the inclusion criteria for this review
(Figure 2).
Trial Characteristics
Sample size and allocation of twins. The sample size var-
ied greatly across the RCTs included in the review. Table 1
illustrates that 42%ofRCTshad a sample size that fell within
10–100 twin pairs. Twenty four percent of the studies had
a sample size smaller than 10 twin pairs as research partici-
pants. Therefore, the majority of studies had 100 twin pairs
or fewer as participants.
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FIGURE 2
PRISMA diagram to illustrate the literature search process and the resulting number of reviewed articles found in the Medline, Psych
INFO and EMBASE databases.
Zygosity and twin assignment across the randomized
controlled trials. As illustrated in Table 1, 13 RCTs as-
signed both twins in a pair to the same study arm, 10 of
which included both MZ and DZ twins, two included only
MZ twins, and one included only DZ twins. This is in con-
trast to 33 RCTs where twin pairs were assigned to different
study arms, of which 6 included both MZ and DZ twins, 24
included only MZ twins, and 3 included only DZ twins. In
most instances (33/50) the pair of twins had been assigned
to different study arms, and most of these studies (24/33)
had been with MZ twins.
Location of studies. The vast majority of the studies in-
cluded in this review were conducted in the United States
(21). The remaining studies were from Canada (5), Aus-
tralia (3), United Kingdom (3), Finland (2), Germany (2),
Greece (2), and one from each of the following coun-
tries; Bangladesh, Belgium, Dominican Republic, France,
Hawaii, Hong Kong, India, Iran, Norway, Switzerland, Tai-
wan, and Thailand. A twin registry had been used to sup-
port recruitment in eight of the RCTs. These were the
Australian Twin Registry (3), the Twin Research Registry,
United Kingdom (3), the St. Thomas UK Adult Twin Reg-
istry (1), and the University of Washington Twin Registry
(1). In the remaining 39 studies, there was no evidence of a
twin registry being used to support recruitment. RCTs were
diverse in nature, and areas included preterm birth nutri-
tion, behavior, dental health, antiviral treatments, and co-
bedding of twins (twin infants sleeping together).
Discussion
RCTs involving only twins as participants are limited, as
shown by this review. Only 50 studiesmet our inclusion cri-
teria after a comprehensive search in clinical trials andNHS
library databases, even across a wide range of disciplines.
Out of the 186,027 clinical trials registered in the U.S. clin-
ical trial register, only six RCTs used twins as participants.
While it is impossible to determine how many RCTs had
been reported through PubMed and other databases in to-
tal, it is clear that the number of twinRCTs is disproportion-
ate to the number involving singletons. Therefore, it can be
concluded that specifically using twins in RCTs is not com-
mon compared to using singletons.
Randomization of Twins in a RCT
When twins participate in a clinical trial, they may be ran-
domized to the same treatment group, independent of each
other, or to different treatment groups as in the co-twin
control design. Our review found that most clinical trials
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TABLE 1
Characteristics of Randomized Controlled Trials With Twin
Participants
Number (percentage)
Characteristic of trials (n = 50)
Number of participants recruited
<10 12 (24)
10–100 21 (42)
101–250 14 (28)
>250 3 (6)
Sex
Males only 7 (14)
Females only 9 (18)
Males and females 34 (68)
Age group
Infants only 11 (22)
Child and adolescents only 16 (32)
Adolescents and adults 3 (6)
Adults only 20 (40)
Twin assignment
Same treatment groups 13 (26)
Different treatment groups 33 (66)
Independent allocation 3 (6)
Unclear 1 (2)
Location
United States 21 (42)
Canada 5 (10)
Europe 10 (20)
LMIC 2 (4)
Other 12 (24)
Twin recruitment method
Twin registry 8 (16)
Other 42 (84)
used the co-twin control design with MZ twins. Therefore,
it could be concluded that in the majority of studies, MZ
twins had been used for perfect control of genetic varia-
tion between the treatment groups. Recent work suggests
that twins and their parents have a strong preference for as-
signing both twins to the same treatment group, rather than
using the co-twin control design (Bernardo et al., 2015).
This has important implications for future RCTs conducted
in twins, since recruitment may be more successful if both
twins in a pair will receive the same treatment, although the
impact of different methods of randomizing twins on the
sample size must also be considered.
The Impact of Twins on Sample Size and Power
The sample size of trials included in our review ranged from
2 to 1,162 (Table 1) and in the majority of trials (64%), the
sample size was 100 or less. Although we did not attempt to
assess whether the sample size was adequate for address-
ing the specific research question of each trial, this does
raise the issue of whether small RCTs involving twins are
adequately powered to detect meaningful treatment effects.
One of the advantages of conducting RCTs in twins is that
the sample sizes can be less compared to using non-twin
RCTs (Carr et al., 1981; Martin et al., 1982; Miller et al.,
1995). However, this will depend on how twins from the
same pair are randomized. If the co-twin control design is
used, such that one twin from each pair receives the inter-
vention and the other acts as their control, the trial will have
more power than a trial in singletons, and hence the sample
size can be reduced. In contrast, if both twins are assigned to
the same treatment group, the trial will have less power than
a trial in singletons, thus requiring a larger sample size. This
is due to the fact that comparisons of the intervention and
control conditions must be made across twin pairs, rather
than within twin pairs as in the co-twin control design. If
twins from the same pair are randomized independently
(ignoring that they are twins and treating as individuals),
the trial will likely have similar power to a trial in single-
tons. Methods for calculating the sample size for trials in-
volving twins only or a combination of singletons and twins
have been discussed elsewhere (Yelland et al., 2017).
International Collaborations Using Twin Registries
We found that only 11/50 (22%) of the studies used
twin registries for recruitment. One option particularly for
multi-center RCTs with a relatively large sample size is in-
ternational collaboration, as currently utilized in non-RCT
twin research (Buchwald et al., 2014). The CODA Twins
project was a classic example initiated in 2013 by identi-
fying all twin projects in the world. It comprises 67 twin
projects having data from both MZ and DZ twin pairs. The
main sources used to identify the projects were a special is-
sue of Twin Research and Human Genetics (Hur & Craig
2013), and the participants of the INTR (Buchwald et al.,
2014; van Dongen et al., 2012). The INTR is a platform for
international collaborations and would be an excellent re-
source for large-scale multicenter clinical trials.
Implications for Future Work and Directions
To understand the potential benefits of the co-twin control
design, it would be useful to compare the sample sizes of
twin RCTs and non-twin RCTs required to detect the same
effect size. The advantages and disadvantages of inclusion of
both MZ and DZ twins in RCTs needs more in-depth dis-
cussion and are areas for future methodological research.
Contamination between intervention and control twin par-
ticipants allocated to different treatment groups (partic-
ularly in psychological interventions), especially among
twins living together, will be an important issue to address.
Limitation of the Review
In-depth analyses of the quality of individual 50 studies
qualified for the review and methodological issues of these
studies were not done. We did not include a meta-analysis
for this review.
Conclusion
Both MZ and DZ twins have been used in RCTs. However,
in amajority of instances they have beenMZ twins random-
ized to opposite arms of a RCT.
The continuous development and implementation of in-
novative twin designs in intervention studies, especially
RCTs, indicates that twin research can extend beyond the
TWIN RESEARCH AND HUMAN GENETICS 5
https://www.cambridge.org/core/terms. https://doi.org/10.1017/thg.2017.67
Downloaded from https://www.cambridge.org/core. IP address: 90.210.117.37, on 29 Dec 2017 at 10:26:04, subject to the Cambridge Core terms of use, available at
Athula Sumathipala et al.
more widely recognized heritability estimates toward the
possibility of inference on causation.
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